DAVA Oncology Information

DAVA Oncology was founded in 2007 with the goal of facilitating successful cancer drug development by providing innovative solutions and services to the pharmaceutical and biotechnology industries. DAVA has three business units - DAVA Clinical Trial Acceleration Services, Oncology Meeting Innovations and ONE Oncology. These business units accelerate clinical trial research timelines through MD-to-MD focused trial education, host non-CME scientific exchange programs across more than fifteen solid tumor and hematologic malignancies and create both custom and syndicated oncology education tools, respectively.